← Leaderboards
Upal Roy
University Of Texas Rio Grande Valley
$3,764,318
Attributed
$3,764,318
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $681.8K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,764,318 · 2
By mechanism
R01$3,331,589 · 1
R15$432,729 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Rio Grande Valley
Same institution · by research overlap
- Javier Macossay-Torres$425,228
- Nirakar Sahoo$444,000
Others in their field
Other Emerging Leaders on “Formulation”
- Matthew Johnson · Duke University$56,071,536
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Xinhua Li · Nano Terra, Inc.$35,520,438
- Nader Fotouhi · Global Alliance For Tb Drug Development$28,468,137
- Jay Evans · University Of Montana$27,950,292
- Kristin Aillon · Midwest Research Institute$24,965,877
Research focus
FormulationIn VivoDrug KineticsEnvironmentInnovationIn VitroDrug Delivery SystemsDrug FormulationsDrug TargetingEncapsulatedDoseHiv-1AreaInterestAnti-Hiv AgentsCause Of DeathBindingAcquired Immunodeficiency SyndromeAnti-Retroviral AgentsCollaborationsAntiretroviral TherapyCellsAntibodiesLegal Patent
Grant awards (7)
A targeted anti-HIV drug delivery to the GALT$554,550
R01 · FY2025 · AI · contact PI
A targeted anti-HIV drug delivery to the GALT$561,283
R01 · FY2024 · AI · contact PI
A targeted anti-HIV drug delivery to the GALT$561,283
R01 · FY2023 · AI · contact PI
A targeted anti-HIV drug delivery to the GALT$314,734
R01 · FY2022 · AI · contact PI
A targeted anti-HIV drug delivery to the GALT$657,928
R01 · FY2021 · AI · contact PI
A targeted anti-HIV drug delivery to the GALT$681,811
R01 · FY2020 · AI · contact PI
Nanodiamond based anti-HIV drug delivery targeted towards the brain$432,729
R15 · FY2018 · NS · contact PI